Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Combined Pharmacologic and Nutritional Modulation of High-Fat Diet-Associated Tumor-Supportive Features in Prostate Cancer Models.
Journal: Biomolecules
Published: May 13, 2026
Arctigenin Suppresses Breast Cancer Growth In Vitro and In Vivo Through Subtype-Specific Multi-Targeting Activity.
Journal: International journal of molecular sciences
Published: April 26, 2026
Corrigendum Engineering of layer-by-layer acetate coated paclitaxel loaded poly(lactide-co-glycolide acid nanoparticles for prostate cancer therapy- in vitro [Journal of Pharmaceutical Sciences Volume 113, Issue 11, November 2024, Pages 3375-3383].
Journal: Journal of pharmaceutical sciences
Published: February 21, 2026
Correction: Tian et al. Diaporine Potentiates the Anticancer Effects of Oxaliplatin and Doxorubicin on Liver Cancer Cells. J. Pers. Med. 2022, 12, 1318.
Journal: Journal of personalized medicine
Published: January 14, 2026
ATP-dependent remodeling of chromatin condensates reveals distinct mesoscale outcomes.
Journal: Science (New York, N.Y.)
Published: October 02, 2025
Overcoming Challenges in Small-Molecule Drug Bioavailability: A Review of Key Factors and Approaches.
Journal: International journal of molecular sciences
Published: October 29, 2024
ATP-dependent remodeling of chromatin condensates uncovers distinct mesoscale effects of two remodelers.
Journal: bioRxiv : the preprint server for biology
Published: September 24, 2024
Engineering of layer-by-layer acetate-coated paclitaxel loaded poly(lactide-co-glycolide) acid nanoparticles for prostate cancer therapy- in vitro.
Journal: Journal of pharmaceutical sciences
Published: August 14, 2024
Small Molecule Topical Ophthalmic Formulation Development-Data Driven Trends & Perspectives from Commercially Available Products in the US.
Journal: Journal of pharmaceutical sciences
Published: May 07, 2024
Wip1 phosphatase activator QGC-8-52 specifically sensitizes p53-negative cancer cells to chemotherapy while protecting normal cells.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: April 15, 2024
A rapid solid form risk assessment workflow for ophthalmic drug candidates.
Journal: Drug development and industrial pharmacy
Published: June 12, 2023
Last Updated: 09/26/2026